Delivery Order SPE2DB20D1109-SPE2DB23FP12X
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Dupixent 300 mg/2 ml pen, a specialty pharmaceutical product. The contract has a ceiling value of $8,120.55 and an ultimate completion date of April 25, 2023. This contract is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Dupixent 300 mg/2 ml pens, a pharmaceutical product used for medical treatment. The Delivery Order has a ceiling value of $24,455.91 and was awarded on February 23, 2022, with a completion date of February 24, 2022. This contract is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc....
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen, with a ceiling value of $11,566.52 and a period of performance ending on July 11, 2022. The contract did not have a set-aside designation, indicating open competition. This delivery order is part of a larger Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Dupixent 300 mg/2 ml pens. The award is under a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The delivery order has a ceiling value of $2,489.46 and is a firm fixed-price...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $8,616.91, is for the supply of a specialty pharmaceutical product, Dupixent 300 mg/2 ml pen, in support of military treatment programs and facilities. The delivery order falls under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen. The award, with a ceiling value of $3,304.72, is a firm fixed-price contract that will run through April 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and expiring in...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Dupixent 300 mg/2 ml pens. The award has a ceiling value of $6,837.84 and a completion date of February 4, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive...
- This is a $10,602.75 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Dupixent 300 mg/2 ml pens for an ultimate completion date of December 5, 2024. This delivery order is under a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $6,609.40 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4564404197 Dupixent 300 mg/2 ml pens. The contract has an ultimate completion date of April 26, 2024 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Dupixent 300 mg/2 ml pens. The delivery order, valued at $1,871.17, was issued under an Indefinite Delivery Contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FP12XDelivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Dupixent 200 mg/1.14 ml pens, a specialty pharmaceutical product. The award has a ceiling value of $8,646.83 and an ultimate completion date of May 16, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This particular delivery order was not designated with a set-aside requirement, indicating full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 5/15/23 |